ID | Retention Time (min) | m/z | Human Plasma Level | % Conversion (% of Total Radioactivity Profile) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HLM | CYP3A4 | CYP3A5 | 2D6 | 2C19 | 1A2 | 1A1 | 2B6 | 4F3A | |||||||
5 μM | 20 μM | 5 μM | 20 μM | 5 μM | 20 μM | 5 μM | 5 μM | 5 μM | 5 μM | 5 μM | 5 μM | ||||
M1 | 13.7 | 552 | N.D.a | N.D. | 1.80 | N.D. | 0.33 | 2.68 | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. |
M3 | 16.2 | 554 | Traceb | N.D. | N.D. | 5.20 | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. |
M4 | 16.6 | 368 | Trace | 4.20 | 1.10 | 4.57 | 0.58 | 2.22 | <0.81 | N.D. | 0.29 | 0.29 | 0.33 | 0.22 | 0.24 |
M5 | 17.6 | 552 | Trace | 7.70 | 3.81 | 0.80 | 0.90 | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. | |
M8 | 19.2 | 538 | Trace | N.D. | 1.10 | N.D. | N.D. | N.D. | N.D. | N.D. | 0.49 | N.D. | N.D. | N.D. | N.D. |
M9 | 19.7 | 552 | Trace | 7.12 | 4.99 | 1.59 | 3.01 | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. | |
M10 | 20.2 | 554 | Trace | N.D. | N.D. | N.D. | 5.35 | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. |
M11 | 20.3 | 536 | Trace | 8.08 | 11.0 | 1.12 | 21.32 | 10.67 | 2.74 | N.D. | N.D. | N.D. | N.D. | N.D. | |
M14 | 21.7 | 552 | Trace | 10.12 | <4.79 | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. |
M15 | 22.2 | 367 | Minorc | <3.45 | <4.64 | 15.74 | 2.87 | 1.90 | N.D. | 1.37 | 2.90 | 2.06 | 0.61 | ||
M16 | 22.5 | 536 | Trace | N.D. | N.D. | N.D. | N.D. | N.D. | |||||||
M18 | 22.9 | 552 | Trace | <6.39 | N.D. | 3.24 | 1.32 | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. | |
M21 | 26.9 | 536 | Trace | 6.00 | 9.70 | 0.32 | <4.56 | 15.34 | 9.38 | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. |
M22 | 27.2 | 538 | Minor | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. | 0.83 | N.D. | N.D. | N.D. | N.D. |
M23 | 29.9 | 536 | Minor | <9.21 | <12.8 | 1.12 | <7.99 | <7.94 | <6.02 | 0.38 | N.D. | N.D. | N.D. | N.D. | N.D. |
M24 | 33.1 | 536 | Minor | 2.42 | <2.68 | 0.25 | 1.27 | 6.96 | 2.39 | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. |
M25 | 34.2 | 536 | Trace | 0.13 | 0.36 | N.D. | N.D. | 0.82 | 0.25 | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. |
M28 | 40.1 | 522 | Majord | N.D. | 0.60 | N.D. | BIT | N.D. | BIT | 0.56 | 0.38 | 0.34 | 0.57 | 0.90 | 1.78 |
M30 | 41.2 | 522 | Major | N.D. | N.D. | N.D. | N.D. | N.D. | BIT | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. |
Boceprevir (SCH 534128) | 42.8 | 520 | Major | 0.21 | 26.12e | BIT | 37.98e | 0.98 | 38.77 | 57.22 | 60.3 | 59.66 | 55.46 | 56.54 | 57.31 |
M31 | 43.1 | 522 | Major | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. | N.D. | ||
Boceprevir (SCH 534129) | 44.6 | 520 | Major | 0.31 | 17.42 | BIT | 18.98 | 2.19 | 19.67 | 31.66 | 30.71 | 31.72 | 33.40 | 33.77 | 34.35 |
M32 | 48.8 | 463 | Trace | N.D. | 0.35 | N.D. | 0.97 | 0.11 | 0.88 | N.D. | 1.06 | 2.18 | 2.32 | 1.29 | 0.65 |
↵a ID, identification; HLM, human liver microsomes; N.D., not detected; BIT, below integration threshold of radiometric detector but detected by mass spectrometer. Only metabolites detected in human plasma are listed in the table. Sum of boceprevir = SCH 534128 + SCH 534129.
↵b Trace is defined as the percent ratio of extracted ion chromatogram (XIC) area for the metabolites (all known isomers) to that for parent (two isomers) is ≤10%.
↵c Minor is defined as the percent ratio of XIC area for the metabolites (all known isomers) to that for parent (two isomers) is between 10 and 50%.
↵d Major is defined as the percent ratio of XIC area for the metabolites (all known isomers) to that for parent (two isomers) is ≥50%.
↵e M31 is a minor component coeluting with boceprevir.